Your browser doesn't support javascript.
loading
Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
Ye, Gang; Pan, Ruangang; Bu, Fan; Zheng, Jian; Mendoza, Alise; Wen, Wei; Du, Lanying; Spiller, Benjamin; Wadzinski, Brian E; Liu, Bin; Perlman, Stanley; Li, Fang.
Affiliation
  • Ye G; Department of Pharmacology, University of Minnesota Medical School , Minneapolis, Minnesota, USA.
  • Pan R; Center for Coronavirus Research, University of Minnesota , Minneapolis, Minnesota, USA.
  • Bu F; Department of Microbiology and Immunology, University of Iowa , Iowa City, Iowa, USA.
  • Zheng J; Department of Pharmacology, University of Minnesota Medical School , Minneapolis, Minnesota, USA.
  • Mendoza A; Center for Coronavirus Research, University of Minnesota , Minneapolis, Minnesota, USA.
  • Wen W; Hormel Institute, University of Minnesota , Austin, Minnesota, USA.
  • Du L; Department of Microbiology and Immunology, University of Iowa , Iowa City, Iowa, USA.
  • Spiller B; Department of Pharmacology, University of Minnesota Medical School , Minneapolis, Minnesota, USA.
  • Wadzinski BE; Center for Coronavirus Research, University of Minnesota , Minneapolis, Minnesota, USA.
  • Liu B; Department of Pharmacology, University of Minnesota Medical School , Minneapolis, Minnesota, USA.
  • Perlman S; Center for Coronavirus Research, University of Minnesota , Minneapolis, Minnesota, USA.
  • Li F; Institute for Biomedical Sciences, Georgia State University , Atlanta, Georgia, USA.
J Virol ; 97(11): e0144823, 2023 Nov 30.
Article in En | MEDLINE | ID: mdl-37855638

Full text: 1 Database: MEDLINE Main subject: Single-Domain Antibodies / SARS-CoV-2 / COVID-19 Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Single-Domain Antibodies / SARS-CoV-2 / COVID-19 Limits: Humans Language: En Year: 2023 Type: Article